Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
See All Experts
featured
Published in Primary Care and
2 other channels

Journal Scan / Research · December 01, 2022

Effect of Metformin on COVID-19 Severity in Patients With Prediabetes

Diabetes Research and Clinical Practice

 

 Save  Recommend
 Share

Additional Info

Diabetes Research and Clinical Practice
Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes
Diabetes Res. Clin. Pract. 2022 Dec 01;194(xx)110157, LE Chan, E Casiraghi, B Laraway, B Coleman, H Blau, A Zaman, N Harris, K Wilkins, M Gargano, G Valentini, D Sahner, M Haendel, PN Robinson, C Bramante, J Reese

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated